10-Q Filing

ALKERMES PLC. CIK: 1520262 Q1 2017

Filing Information

Form Type	10-Q
Accession Number	`0001520262-17-000020`
Period End Date	20170331
Filing Date	20170427
Fiscal Year	2017
Fiscal Period	Q1
XBRL Instance	alks-20170331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 46 Cash Flow Statement 59 Comprehensive Income 2

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Preferred stock shares, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock shares, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock shares, authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Preferred stock shares, authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Preferred stock shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$199.98M	USD	Point-in-time
Preferred stock shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$186.38M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$181.31M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$181.11M	USD	Point-in-time
Investments - short-term	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$310.86M	USD	Point-in-time
Investments - short-term	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$295.11M	USD	Point-in-time
Preferred stock shares, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock shares, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$176.49M	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$191.10M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	450.00M	shares	Point-in-time
Inventory	`InventoryNet`	$63.00M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	450.00M	shares	Point-in-time
Inventory	`InventoryNet`	$63.67M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	155.11M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$42.28M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$39.34M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	154.19M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$790.68M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	153.12M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	152.43M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$758.85M	USD	Point-in-time
INTANGIBLE ASSETS - NET	`IntangibleAssetsNetExcludingGoodwill`	$318.23M	USD	Point-in-time
INTANGIBLE ASSETS - NET	`IntangibleAssetsNetExcludingGoodwill`	$302.93M	USD	Point-in-time
Treasury stock shares	`TreasuryStockCommonShares`	1.76M	shares	Point-in-time
Treasury stock shares	`TreasuryStockCommonShares`	1.99M	shares	Point-in-time
PROPERTY, PLANT AND EQUIPMENT, NET	`PropertyPlantAndEquipmentNet`	$264.92M	USD	Point-in-time
PROPERTY, PLANT AND EQUIPMENT, NET	`PropertyPlantAndEquipmentNet`	$264.79M	USD	Point-in-time
INVESTMENTS - LONG-TERM	`MarketableSecuritiesNoncurrent`	$121.93M	USD	Point-in-time
INVESTMENTS - LONG-TERM	`MarketableSecuritiesNoncurrent`	$112.95M	USD	Point-in-time
GOODWILL	`Goodwill`	$92.87M	USD	Point-in-time
GOODWILL	`Goodwill`	$92.87M	USD	Point-in-time
CONTINGENT CONSIDERATION	`BusinessCombinationContingentConsiderationAssetNoncurrent`	$63.20M	USD	Point-in-time
CONTINGENT CONSIDERATION	`BusinessCombinationContingentConsiderationAssetNoncurrent`	$64.80M	USD	Point-in-time
DEFERRED TAX ASSETS	`DeferredTaxAssetsGrossNoncurrent`	$47.77M	USD	Point-in-time
DEFERRED TAX ASSETS	`DeferredTaxAssetsGrossNoncurrent`	$106.75M	USD	Point-in-time
OTHER ASSETS	`OtherAssetsNoncurrent`	$25.76M	USD	Point-in-time
OTHER ASSETS	`OtherAssetsNoncurrent`	$26.96M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.73B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.73B	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$207.06M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$205.31M	USD	Point-in-time
Long-term debt - short-term	`LongTermDebtCurrent`	$3.00M	USD	Point-in-time
Long-term debt - short-term	`LongTermDebtCurrent`	$3.00M	USD	Point-in-time
Deferred revenue - short-term	`DeferredRevenueCurrent`	$2.43M	USD	Point-in-time
Deferred revenue - short-term	`DeferredRevenueCurrent`	$1.94M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$210.74M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$211.99M	USD	Point-in-time
LONG-TERM DEBT	`LongTermDebtNoncurrent`	$280.67M	USD	Point-in-time
LONG-TERM DEBT	`LongTermDebtNoncurrent`	$280.11M	USD	Point-in-time
OTHER LONG-TERM LIABILITIES	`OtherLiabilitiesNoncurrent`	$17.16M	USD	Point-in-time
OTHER LONG-TERM LIABILITIES	`OtherLiabilitiesNoncurrent`	$15.75M	USD	Point-in-time
DEFERRED REVENUE - LONG-TERM	`DeferredRevenueNoncurrent`	$7.12M	USD	Point-in-time
DEFERRED REVENUE - LONG-TERM	`DeferredRevenueNoncurrent`	$6.52M	USD	Point-in-time
Total liabilities	`Liabilities`	$513.12M	USD	Point-in-time
Total liabilities	`Liabilities`	$516.94M	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred shares, par value, $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at March 31, 2017 and December 31, 2016, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred shares, par value, $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at March 31, 2017 and December 31, 2016, respectively	`PreferredStockValue`	-	USD	Point-in-time
Ordinary shares, par value, $0.01 per share; 450,000,000 shares authorized; 155,109,810 and 154,191,281 shares issued; 153,122,812 and 152,430,514 shares outstanding at March 31, 2017, and December 31, 2016, respectively	`CommonStockValue`	$1.55M	USD	Point-in-time
Ordinary shares, par value, $0.01 per share; 450,000,000 shares authorized; 155,109,810 and 154,191,281 shares issued; 153,122,812 and 152,430,514 shares outstanding at March 31, 2017, and December 31, 2016, respectively	`CommonStockValue`	$1.54M	USD	Point-in-time
Treasury shares, at cost (1,986,998 and 1,760,767 shares at March 31, 2017 and December 31, 2016, respectively)	`TreasuryStockCommonValue`	$85.83M	USD	Point-in-time
Treasury shares, at cost (1,986,998 and 1,760,767 shares at March 31, 2017 and December 31, 2016, respectively)	`TreasuryStockCommonValue`	$72.64M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.23B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.26B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.20M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.27M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-955.30M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-947.94M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$1.22B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$1.21B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$1.73B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$1.73B	USD	Point-in-time

Income Statement 46 line items

Line Item	Tag	Value	Unit	Period
Manufacturing and royalty revenues	`ManufacturingAndRoyaltyRevenues`	$114.68M	USD	1 Quarter
Manufacturing and royalty revenues	`ManufacturingAndRoyaltyRevenues`	$106.16M	USD	1 Quarter
Product sales, net	`SalesRevenueGoodsNet`	$49.37M	USD	1 Quarter
Product sales, net	`SalesRevenueGoodsNet`	$76.46M	USD	1 Quarter
Research and development revenue	`ContractsRevenue`	$643.00K	USD	1 Quarter
Research and development revenue	`ContractsRevenue`	$1.24M	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$191.78M	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$156.77M	USD	1 Quarter
Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below)	`CostOfGoodsSold`	$27.71M	USD	1 Quarter
Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below)	`CostOfGoodsSold`	$40.41M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$104.83M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$101.07M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$102.10M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$89.72M	USD	1 Quarter
Amortization of acquired intangible assets	`AmortizationOfIntangibleAssets`	$15.30M	USD	1 Quarter
Amortization of acquired intangible assets	`AmortizationOfIntangibleAssets`	$15.16M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$233.66M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$262.65M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-70.87M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-76.88M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.01M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$943.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$3.29M	USD	1 Quarter
Interest expense	`InterestExpense`	$2.76M	USD	1 Quarter
Increase in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$1.90M	USD	1 Quarter
Increase in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$1.60M	USD	1 Quarter
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$249.00K	USD	1 Quarter
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$-1.50M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-1.72M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-135.00K	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-77.02M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-72.59M	USD	1 Quarter
(BENEFIT) PROVISION FOR INCOME TAXES	`IncomeTaxExpenseBenefit`	$404.00K	USD	1 Quarter
(BENEFIT) PROVISION FOR INCOME TAXES	`IncomeTaxExpenseBenefit`	$-3.71M	USD	1 Quarter
NET LOSS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-68.88M	USD	1 Quarter
NET LOSS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-77.42M	USD	1 Quarter
Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.51	USD	1 Quarter
Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.45	USD	1 Quarter
Basic and Diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	150.82M	shares	1 Quarter
Basic and Diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	152.70M	shares	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-77.42M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-68.88M	USD	1 Quarter
Holding gain, net of a tax provision of $23 and $425, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$935.00K	USD	1 Quarter
Holding gain, net of a tax provision of $23 and $425, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$72.00K	USD	1 Quarter
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-76.49M	USD	1 Quarter
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-68.81M	USD	1 Quarter

Cash Flow Statement 59 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-77.42M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-68.88M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$23.76M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$22.70M	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$24.26M	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$21.17M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-25.44M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-1.22M	USD	1 Quarter
Excess tax benefit from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$4.87M	USD	1 Quarter
Increase in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$1.90M	USD	1 Quarter
Increase in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$1.60M	USD	1 Quarter
Other non-cash charges	`OtherNoncashExpense`	$1.62M	USD	1 Quarter
Other non-cash charges	`OtherNoncashExpense`	$672.00K	USD	1 Quarter
Receivables	`IncreaseDecreaseInReceivables`	$-14.62M	USD	1 Quarter
Receivables	`IncreaseDecreaseInReceivables`	$-15.67M	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$733.00K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$7.98M	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesAndOtherAssets`	$2.90M	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesAndOtherAssets`	$3.67M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-680.00K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.73M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-105.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-442.00K	USD	1 Quarter
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$1.89M	USD	1 Quarter
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$2.25M	USD	1 Quarter
Cash flows used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-13.75M	USD	1 Quarter
Cash flows used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-57.21M	USD	1 Quarter
Additions of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$12.01M	USD	1 Quarter
Additions of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$9.38M	USD	1 Quarter
Proceeds from the sale of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$3.00K	USD	1 Quarter
Proceeds from the sale of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$7.00K	USD	1 Quarter
Investment in Reset Therapeutics, Inc.	`PaymentsToAcquireEquityMethodInvestments`	$15.00M	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$30.16M	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$58.53M	USD	1 Quarter
Sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$55.00M	USD	1 Quarter
Sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$158.22M	USD	1 Quarter
Cash flows provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$15.46M	USD	1 Quarter
Cash flows provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$72.69M	USD	1 Quarter
Proceeds from the issuance of ordinary shares under share-based compensation arrangements	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$7.11M	USD	1 Quarter
Proceeds from the issuance of ordinary shares under share-based compensation arrangements	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$3.50M	USD	1 Quarter
Excess tax benefit from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$4.87M	USD	1 Quarter
Employee taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$13.15M	USD	1 Quarter
Employee taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$3.30M	USD	1 Quarter
Principal payments of long-term debt	`RepaymentsOfLongTermDebt`	$1.69M	USD	1 Quarter
Principal payments of long-term debt	`RepaymentsOfLongTermDebt`	$750.00K	USD	1 Quarter
Cash flows (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-6.78M	USD	1 Quarter
Cash flows (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$3.39M	USD	1 Quarter
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$18.87M	USD	1 Quarter
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-5.07M	USD	1 Quarter
CASH AND CASH EQUIVALENTS - Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$181.31M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$186.38M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$181.11M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$199.98M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - End of period	`CashAndCashEquivalentsAtCarryingValue`	$181.31M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - End of period	`CashAndCashEquivalentsAtCarryingValue`	$186.38M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - End of period	`CashAndCashEquivalentsAtCarryingValue`	$181.11M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - End of period	`CashAndCashEquivalentsAtCarryingValue`	$199.98M	USD	Point-in-time
Purchased capital expenditures included in accounts payable and accrued expenses	`NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1`	$3.10M	USD	1 Quarter
Purchased capital expenditures included in accounts payable and accrued expenses	`NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1`	$4.98M	USD	1 Quarter

Comprehensive Income 2 line items

Line Item	Tag	Value	Unit	Period
Tax provision	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$425.00K	USD	1 Quarter
Tax provision	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$23.00K	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.